Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

US-China relations: Pentagon's update on Monday comes months after it briefly released -- then withdrew -- an earlier version of the list w...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Quant Mutual Fund is strategically focusing on under-owned, under-researched, and neglected market segments for higher alpha generation. Th...

Houston, Texas is leading corporate headquarters relocations, attracting 192 companies since 2018. Businesses are leaving California due to...

US Ambassador to India Sergio Gor on Friday placed pharmaceuticals and the Pax Silica technology partnership at the centre of the growing I...

A new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...

SEBI chief Tuhin Kanta Pandey emphasized India remains a diversified market despite Taiwan overtaking its market value. Driven by TSMC and ...

Investors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...

Amid ongoing legal disputes, the Delhi High Court is probing Fortis Healthcare's oversight concerning the sale of shares belonging to the S...

Prime Minister Modi's gift of a Parle Melody toffee to Italy's Giorgia Meloni symbolised India's evolving soft power. Beyond traditional ex...

Investors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...

In a recent turn of fortunes, Indian stock markets experienced a notable rise for the second consecutive day. On Thursday, both the Sensex ...

Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...

A significant legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. The Tokyo District Court will announce its jud...

A major legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. IHH's subsidiary, NTK, is seeking JPY 200 billion in...

Sun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...